Quince Therapeutics, Inc.
QNCX·NasdaqGS
31.73+2.37 (+8.07%)today
At close: Oct 9, 4:00 PM EDT · May be delayed up to 15 min · USD
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close29.36
Open30.50
Day range29.8437.00
52-week range15.10910.00
Off day high−14.24%
Off 52-week high−96.51%
Volume138.74K
Avg. volume (3M)30.63K
Market cap32.27M
EPS (TTM)-214.01
Forward P/E-6.78
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding1.02M
Short interest—
Earnings dateAug 14, 2026 (est.)
Analyst target—
Profit margin—
Against its peers
Compare in full ›| QNCX | ATHE | VYGR | QNTM | ABVC | GANX | |
|---|---|---|---|---|---|---|
| Market cap | 32.27M | 53.35M | 139.87M | 18.13M | 26.16M | 68.52M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -6.8 | -3.1 | -1.8 | -0.4 | -2.2 | -2.3 |
| Price/book | -0.9 | 1.8 | 0.9 | 2.7 | 2.4 | 6.0 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −91.91% | −38.05% | −49.90% | −80.65% | −67.11% | −13.68% |
| Today | +8.07% | −6.98% | −7.35% | −4.08% | −2.02% | −4.27% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All QNCX news ›No recent coverage in the 4Search index.
From articles in the 4Search news index.